Relmada Therapeutics director buys $64,750 in company stock

Tomas Kauer - Moderator

Sep 12, 2024 - 06:00

Relmada Therapeutics director buys $64,750 in company stock

Tags:

Previous Article

Cyanotech executive Michael A. Davis buys shares worth $8,350

Humacyte CEO sells over $2.3 million in company stock

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Tomas Kauer - Moderator

Related Posts

Native Union’s clever little combo charger just earned a spot in my travel bag

Native Union’s clever little combo charger just earned ...

Tomas Kauer - Mode... Oct 25, 2024

AI networking startup Boardy raises $3M pre-seed

AI networking startup Boardy raises $3M pre-seed

Tomas Kauer - Mode... Oct 24, 2024

Stocks falter, dollar weak after US presidential debate; CPI in focus

Stocks falter, dollar weak after US presidential debate...

Tomas Kauer - Mode... Sep 11, 2024